Startup Innovation News | October 2021
Start-ups and scale-ups from Germany are constantly in the headlines. Sometimes the efforts of smaller start-ups go unnoticed. Here we showcase selected start-up developments worthy of attention.
Your company is already operating in Germany and you would now like to export worldwide?
Start-ups and scale-ups from Germany are constantly in the headlines. Sometimes the efforts of smaller start-ups go unnoticed. Here we showcase selected start-up developments worthy of attention.
The life sciences sector is carrying out mRNA-based research to develop vaccines for cancer, novel gene and cell therapies to treat Parkinson's, and providing a home for global pandemic research.
Germany’s biotech sector is playing an important role in combating Covid-19. The sector is booming, with major investment bringing increased confidence to an in-demand market.
Germany remains an attractive foreign direct investment (FDI) location for international investors in a diverse number of industries and emerging markets.
The role of biotech companies in the pandemic has highlighted the importance of the medical biotechnology industry and promoted investment in this sector.
Germany's life sciences market continues to attract international investors in sectors ranging from coronavirus vaccine production to medical cannabis products.
Months after the first vaccines were granted approval, Germany continues to play a major role as a production location: with companies entering new alliances and expanding capacities.